Many diagnostic procedures are now available for the assessment of the cirrhotic patient; for example, measurement of serum antibodies against smooth muscle and mitochondria helps in the recognition of active chronic hepatitis and primary biliary cirrhosis, and an important complication of cirrhosis, primary liver cell carcinoma, is more readily diagnosed with the aid of coeliac axis arteriography, liver scintiscanning, and estimation of a-fetoglobin in the patient's serum. In spite of the use of such modern methods, liver biopsy continues to play a part in the diagnosis and management of cirrhotic patients, and concepts of the disease remain firmly based on morphology. This article is an attempt to summarize the different uses of percutaneous biopsies in cirrhotic patients and to review the problems of interpretation caused by the provision of a sample representing perhaps one hundred thousandth of the whole organ.
There is much disagreement on the value of percutaneous, blind needle biopsies in establishing a diagnosis of cirrhosis. Braunstein' took A close relationship exists between the anatomical type and the ease with which cirrhosis can be diagnosed in a needle biopsy. In micronodular or regular cirrhosis the nodules are of the same order of size as the original lobules, and the lesions are regularly distributed throughout the liver. The lesion is therefore likely to be apparent in any needle biopsy of reasonable size. In macronodular or irregular cirrhosis, on the other hand, nodule diameter is often greater than the length of a needle biopsy and the archi-Liver biopsy in the diagnosis of cirrhosis tecture of the nodules may closely resemble that of normal liver. This is especially so in the case of the incomplete septal or 'posthepatitic' variety1415 in which slender septa demarcate large nodules. Because of this difficulty, it is often impossible to exclude cirrhosis entirely by needle biopsy, and diagnosis requires close attention to minor alterations in structure, most easily seen in sections impregnated with silver to demonstrate reticulin fibres. Features which support a diagnosis of macronodular cirrhosis include fragmentation of the biopsy before or during processing in the laboratory, fibrosis, especially when seen as a thin band of fibres at the edge of rounded pieces of liver tissue, structural abnormalities such as unusual relationships between afferent and efferent vessels and excess of the latter, marked variation in liver cell appearance, evidence of regeneration, and absence of lipofuscin pigment.
The problem of assessing the stage which cirrhosis has reached has already been raised in considering different anatomical types. In the case of micronodular cirrhosis, in which sampling error plays a smaller part than in other forms, an impression may be gained that cirrhosis is at an early stage of development on the one hand, or fully developed on the other. In the former case nodules are not well demarcated and it is difficult to decide whether there is fibrosis or cirrhosis. This situation, not uncommon in chronic alcoholics, is of some importance, as the lesion may be arrestable or even to some extent reversible in the early stages.
The activity of cirrhosis is a measure of its rate of progression, as judged histologically by the extent of liver cell necrosis and consequent inflammatory response. Necrosis may be of the type associated with the initial injury, for example, alcoholic or viral hepatitis; alternatively it may take the form of piecemeal necrosis. This does not always correlate well with biochemical and clinical evidence of activity, probably because cirrhosis may vary in activity in different parts of the liver and a small sample is not necessarily representative. It follows that minor variations in activity in consecutive biopsies in one individual patient cannot be taken as proof of the efficacy or otherwise of a mode of treatment. Larger variations, or differences assessed by examination of large series of patients, may nevertheless give useful information.
Lastly, liver biopsy can provide information as to the presence of complications arising in the course of cirrhosis. Heavy cholestasis, acute portal inflammation, and bile duct proliferation may suggest an element of biliary obstruction, but will usually fail to reveal the site of the obstruction; in a substantial proportion of patients the cirrhosis itself appears to give rise to intrahepatic obstruction.16 The chief complication demonstrable by biopsy is primary liver cell carcinoma, and here scintiscanning often enables the biopsy to be taken from a suspect area rather than at random. In the western world the great majority of cases of liver cell carcinoma arises in cirrhotic livers, and the cirrhosis is usually of macronodular or mixed type. '7, '8 Indeed, this It may be concluded that liver biopsy has a useful part to play in the management of the cirrhotic patient, since it provides information of various kinds, not restricted to the bare diagnosis of the disease. At the same time the problems of sampling error and of present lack of knowledge concerning aetiological factors are such that biopsy should be regarded as part of the range of investigations rather than as a final arbiter. It is not uncommon for a liver biopsy to raise a strong suspicion that the patient has cirrhosis, without the diagnosis being fully proven. In such cases a combination of other tests may substantiate or refute the diagnosis, and the role of liver biopsy in cirrhosis is not thereby lessened.
